Imperial College London

Professor Neil Poulter

Faculty of MedicineSchool of Public Health

Professor of Preventive Cardiovascular Medicine.
 
 
 
//

Contact

 

+44 (0)20 7594 3446n.poulter

 
 
//

Assistant

 

Mrs Ranjit Rayat +44 (0)20 7594 3445

 
//

Location

 

55Stadium HouseWhite City Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Zelveian:2020:eurheartj/suaa017,
author = {Zelveian, P and Avagyan, A and Minasyan, A and Hayrumyan, S and Gourgenyan, S and Hakobyan, Z and Kzhdryan, H and Hakobjanyan, V and Ustyan, T and Gharibyan, H and Melkonyan, A and Aroyan, S and Vatinyan, S and Beaney, T and Ster, AC and Poulter, NR},
doi = {eurheartj/suaa017},
journal = {European Heart Journal Supplements},
pages = {H14--H16},
title = {An analysis of blood pressure screening of 21 112 participants in Armenia: May Measurement Month 2018.},
url = {http://dx.doi.org/10.1093/eurheartj/suaa017},
volume = {22},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Elevated blood pressure (BP) is a growing burden worldwide and is the leading cause of mortality and disability-adjusted life years all over the world. May Measurement Month (MMM) is a global initiative aimed to raise awareness of high BP and to act as a temporary solution to the lack of screening programmes worldwide. An opportunistic cross-sectional survey of volunteers aged ≥18 was carried out in May to July 2018. Blood pressure measurement, the definition of hypertension (HTN) and statistical analysis followed the standard MMM protocol. The study was conducted in public areas (17 sites in Yerevan and 22 in regions), both indoor and outdoor, as well as in 78 primary care centres. A total of 21 112 individuals were screened during MMM18, of which 20 732 had three BP measurements available. The mean age of screened individuals was 46.2 ± 17.3 years, 57.8% were female. At the time of screening, 26.1% were on antihypertensive medication. After imputation, the percentage of participants with HTN was 38.7%, and 76.7% of them were aware of their high BP. Of participants receiving treatment, 47.1% had a controlled BP. MMM18 was the largest BP screening campaign undertaken in Armenia. We found that the proportion of HTN is substantial in Armenia, which may be a vital contributor to the growing burden of non-communicable diseases. Our results also suggest that untreated HTN is common and when treated still not adequately controlled in Armenia. The current situation, with an insufficient control rate of HTN, must be changed as soon as possible.
AU - Zelveian,P
AU - Avagyan,A
AU - Minasyan,A
AU - Hayrumyan,S
AU - Gourgenyan,S
AU - Hakobyan,Z
AU - Kzhdryan,H
AU - Hakobjanyan,V
AU - Ustyan,T
AU - Gharibyan,H
AU - Melkonyan,A
AU - Aroyan,S
AU - Vatinyan,S
AU - Beaney,T
AU - Ster,AC
AU - Poulter,NR
DO - eurheartj/suaa017
EP - 16
PY - 2020///
SN - 1520-765X
SP - 14
TI - An analysis of blood pressure screening of 21 112 participants in Armenia: May Measurement Month 2018.
T2 - European Heart Journal Supplements
UR - http://dx.doi.org/10.1093/eurheartj/suaa017
UR - https://www.ncbi.nlm.nih.gov/pubmed/32884458
UR - https://academic.oup.com/eurheartjsupp/article/22/Supplement_H/H14/5898702
UR - http://hdl.handle.net/10044/1/84425
VL - 22
ER -